Management Services, Llc Cu... Net Worth

The estimated Net Worth of Management Services, Llc Cu... is at least $11.8 Milhão dollars as of 13 June 2022. Management Cu owns over 222,000 units of Molecular Templates Inc stock worth over $304,140 and over the last 5 years Management sold MTEM stock worth over $11,478,000.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Management Cu MTEM stock SEC Form 4 insiders trading

Management has made over 3 trades of the Molecular Templates Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Management bought 222,000 units of MTEM stock worth $197,580 on 13 June 2022.

The largest trade Management's ever made was selling 500,000 units of Molecular Templates Inc stock on 16 September 2020 worth over $6,525,000. On average, Management trades about 340,667 units every 251 days since 2020. As of 13 June 2022 Management still owns at least 222,000 units of Molecular Templates Inc stock.

You can see the complete history of Management Cu stock trades at the bottom of the page.

Insiders trading at Molecular Templates Inc

Over the last 7 years, insiders at Molecular Templates Inc have traded over $22,993,582 worth of Molecular Templates Inc stock and bought 14,744,530 units worth $82,519,716 . The most active insiders traders include Target N Vbb Biotech Ag Bio..., David Hirsch, eCapital Partners Iii, Llc L.... On average, Molecular Templates Inc executives and independent directors trade stock every 47 days with the average trade being worth of $532,718. The most recent stock trade was executed by Target N Vbb Biotech Ag Bio... on 2 April 2024, trading 250,000 units of MTEM stock currently worth $587,500.

What does Molecular Templates Inc do?

molecular templates (mtem) is a clinical-stage biopharmaceutical company targeting a variety of cancers through development of its innovative proprietary engineered toxin body (etb) platform. mtem’s first immunotoxin, mt-3724, is in clinical development for non-hodgkin’s lymphoma. pipeline products for additional oncology targets are being advanced toward clinical development. for more information, please visit mtem’s website at www.mtem.com.

Complete history of Management Cu stock trades at Molecular Templates Inc

Molecular Templates Inc executives and stock owners

Molecular Templates Inc executives and other stock owners filed with the SEC include:

• Eric Poma,
  Chief Executive Officer, Chief Scientific Officer, Director
• Roger Waltzman,
  Chief Medical Officer
• Jason Kim,
  President, Chief Operating Officer
• Adam Cutler,
  Chief Financial Officer, Treasurer, Secretary
• Dr. Eric E. Poma,
  CEO, Chief Scientific Officer & Director
• Dr. Roger J. Waltzman M.B.A., M.D.,
  Chief Medical Officer
• Jason S Kim,
  Pres & COO
• Dr. Roger J. Waltzman,
  Chief Medical Officer
• Corazon Sanders,
  Independent Director
• Harold Selick,
  Chairman of the Board
• Kevin Lalande,
  Independent Director
• David Hirsch,
  Independent Director
• David Hoffmann,
  Independent Director
• Scott Morenstein,
  Independent Director
• Jonathan Lanfear,
  Independent Director
• Michael Dowd,
  Sr. VP of Project & Alliance Management
• Megan C. Filoon,
  Gen. Counsel & Sec.
• Dr. Nenad Sarapa M.D., M.S.,
  Sr. VP of Clinical Devel.
• Dr. Jen-Sing Liu Ph.D.,
  Exec. VP of Manufacturing
• Dr. Erin Willert Ph.D.,
  Exec. VP of R&D
• Dr. Jack Higgins Ph.D.,
  Exec. VP of Operations & Head of Manufacturing
• Kurt Elster,
  Exec. VP of Corp. Devel.
• Sean McLennan,
  Sr. VP of Fin., Controller, Interim Principal Accounting Officer, Interim CFO & Treasurer
• Associates, L.L.C.Morenstei...,
  
• Target N Vbb Biotech Ag Bio...,
  
• Dave Hoffmann,
  Director
• Capital Partners Iii, Llc L...,
  
• Scott Dcdk Associates, L.L....,
  
• Management Services, Llc Cu...,
  
• Sean Mc Lennan,
  See remarks
• Management Services, Llc Cu...,
  
• Gabriela Gruia,
  Director
• Maurizio Voi,
  Chief Medical Officer